❋sustainable MEDICINE COMPANY
Creating Medicines that work well for you.
Kenneth Pharmaceuticals is working to create sustainable medicines that works well for you.
Get Affordable Prescription at Kenneth Pharmacy.
Offering Telehealth at Affordable Prices
Get 1:1 Consultation at Kenneth Pharmaceuticals Inc.
250 years of making New medicine.
Our People
Extraordinary and Unique individuals with goals to make long lasting impact.
Inclusion and Diversity
Diverse and inclusive research environment targeted toward solving human Challenges.
Our Purpose
Our Purpose is to advance scientific research across diverse field.
Our Values
We are focused on life saving research activities for our patients
Our Impact
Our Impact extends beyond traditional research areas, Research is life.
Our Strategy
We are employing day-to-day innovation in our research activities.
Our Mission
Our mission is to advance Scientific-Medicine Research
Our Goal
Our goal is to achieve the global SDGs goal 9 by 2030 as Kenneth Pharmaceuticals State-of-the-art Infrastructures becomes operational.
Pushing the Frontier of therapeutics Antibody discovery
$10,ooo,ooo,oo0
Kenneth Pharmaceuticals Inc developed advanced in vivo discovery approaches that extend beyond traditional antibody technologies into innovative peptide and antibody-derived therapeutic platforms.
KennMouse delivers fully human antibodies
$70,000,000,000
Kenneth Pharmaceuticals Inc. developed advanced antibody technologies designed to expand sequence diversity and support the development of next-generation therapeutic antibodies.
A Unique offering to address critical Industry Need
$50,000,000,000
Kenneth Pharmaceuticals provides advanced transgenic rat Monospecific antibodies, which target a single antigen, and bispecific antibodies, which can target two different antigens.
Human Ig-transgenic chicken for the discovery of therapeutic antibodies
$80,000,000
Our Kennflic was designed based on the KennRat and single rearranged VkJk light chain for the development of bispecific, fully human antibodies
Human Ig-transgenic rats for the discovery of therapeutic antibodies
$100,000,000
If you are looking for transgenic rat antibodies, Kenneth Pharmaceuticals offers specialized rat models called KennRat and KennFlic. These rats are genetically modified to help researchers produce fully human antibodies, including single-target and dual-target (bispecific) antibodies.